ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RX Biosyent Inc

8.51
0.11 (1.31%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Biosyent Inc RX TSX Venture Common Stock
  Price Change Price Change % Share Price Last Trade
0.11 1.31% 8.51 14:59:59
Open Price Low Price High Price Close Price Previous Close
8.50 8.50 8.51 8.51 8.40
more quote information »

Recent News

Date Time Source Heading
4/23/202416:45GLOBEBioSyent to Attend Planet MicroCap Showcase
4/15/202415:31GLOBEBioSyent Announces Extension of RepaGyn® and Proktis-M®..
4/03/202407:00GLOBEFeraMAX® Named #1 Recommended Iron Supplement in Canada by..
4/01/202413:00GLOBEBioSyent to Present at LD Micro New York Investor Conference
3/27/202417:34GLOBEBioSyent Announces Grant of Restricted Share Units
3/13/202416:30GLOBEBioSyent Releases Financial Results for Fourth Quarter and..
3/06/202415:30GLOBEBioSyent Schedules Fourth Quarter and Full Year 2023..
2/21/202407:00GLOBEBioSyent Named to 2024 TSX Venture 50
2/06/202415:30GLOBEBioSyent Declares First Quarter 2024 Dividend
12/13/202307:00GLOBEBioSyent Announces Renewal of Normal Course Issuer Bid
11/20/202307:30GLOBEBioSyent Announces the Availability of Gelclair® in Canada
11/16/202307:00GLOBEBioSyent Releases Q3 and YTD 2023 Financial Results
11/15/202315:34GLOBEBioSyent Declares Fourth Quarter 2023 Dividend
11/09/202307:00GLOBEBioSyent Schedules Q3 and YTD 2023 Earnings Release for..
10/18/202307:00GLOBEBioSyent Launches "menopauseinformation.ca" on World..
8/23/202319:22PRNCATSX Venture Exchange Stock Maintenance Bulletins
8/22/202315:15GLOBEBioSyent Releases Q2 and H1 2023 Financial Results
8/22/202315:01GLOBEBioSyent Declares Third Quarter 2023 Dividend
8/15/202315:30GLOBEBioSyent Schedules Q2 and H1 2023 Earnings Release for..
8/08/202307:00GLOBEBioSyent Launches Inofolic® for Women with Polycystic Ovary..
7/06/202316:53GLOBEBioSyent Pharma to Introduce Gelclair® at AHNS 11th..
6/20/202307:30GLOBEBioSyent Announces Long-term Extension of Cathejell®..
5/31/202316:42GLOBEBioSyent Announces Approval of New Product
5/26/202307:00GLOBEBioSyent Releases Financial Results for Q1 2023
5/25/202316:40GLOBEBioSyent Declares Second Quarter 2023 Dividend
5/18/202307:30GLOBEBioSyent Schedules Q1 2023 Earnings Release for May 26, 2023
5/02/202313:59GLOBEFeraMAX® Named #1 Recommended Iron Supplement in Canada by..

Your Recent History

Delayed Upgrade Clock